Keren J. Carss
BioPharmaceuticals R&D, AstraZeneca
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Author Correction: Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes.
Journal: Nature
Published: March 31, 2026
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes.
Journal: Nature
Published: March 21, 2025
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.
Journal: medRxiv : the preprint server for health sciences
Published: May 20, 2024
Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis.
Journal: Nature genetics
Published: February 07, 2024
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences.
Journal: Nature genetics
Published: September 10, 2023
Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders.
Journal: American journal of human genetics
Published: March 13, 2023
Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank.
Journal: American journal of human genetics
Published: November 21, 2022
Rare variant associations with plasma protein levels in the UK Biobank.
Journal: Nature
Published: October 05, 2022
Using human genetics to improve safety assessment of therapeutics.
Journal: Nature reviews. Drug discovery
Published: September 02, 2022
Exploring the Genetic Architecture of Spontaneous Coronary Artery Dissection Using Whole-Genome Sequencing.
Journal: Circulation. Genomic and precision medicine
Published: May 18, 2022
Last Updated: 09/26/2026